| pubmed-article:20384222 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20384222 | lifeskim:mentions | umls-concept:C0025255 | lld:lifeskim |
| pubmed-article:20384222 | lifeskim:mentions | umls-concept:C0085104 | lld:lifeskim |
| pubmed-article:20384222 | lifeskim:mentions | umls-concept:C1881215 | lld:lifeskim |
| pubmed-article:20384222 | pubmed:dateCreated | 2010-4-13 | lld:pubmed |
| pubmed-article:20384222 | pubmed:abstractText | Materials advances enabled by nanotecbnology have brought about promising approaches to improve the encapsulation mechanism for immunoisolated cell-based drug delivery. Cell-based drug delivery is a promising treatment for many diseases but has thus far achieved only limited clinical success. Treatment of insulin dependent diabetes mellitus (IDDM) by transplantation of pancreatic beta-cells represents the most anticipated application ofcell-based drug delivery technology. This review outlines the challenges involved with maintaining transplanted cell viability and discusses how inorganic nanoporous membranes may be useful in achieving clinical success. | lld:pubmed |
| pubmed-article:20384222 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20384222 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20384222 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20384222 | pubmed:issn | 0065-2598 | lld:pubmed |
| pubmed-article:20384222 | pubmed:author | pubmed-author:DesaiTejalT | lld:pubmed |
| pubmed-article:20384222 | pubmed:author | pubmed-author:MendelsohnAda... | lld:pubmed |
| pubmed-article:20384222 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20384222 | pubmed:volume | 670 | lld:pubmed |
| pubmed-article:20384222 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20384222 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20384222 | pubmed:pagination | 104-25 | lld:pubmed |
| pubmed-article:20384222 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:meshHeading | pubmed-meshheading:20384222... | lld:pubmed |
| pubmed-article:20384222 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20384222 | pubmed:articleTitle | Inorganic nanoporous membranes for immunoisolated cell-based drug delivery. | lld:pubmed |
| pubmed-article:20384222 | pubmed:affiliation | UCSF/UCB Joint Graduate Group in Bioengineering, University of California, San Francisco, University of California, Berkeley, USA. | lld:pubmed |
| pubmed-article:20384222 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20384222 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20384222 | lld:pubmed |
